InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

SAB Biotherapeutics, Inc.

SABS Clue Score34
United States Fiscal year ends December CIK 0001833214
$2.98 +3.11% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.98 −70.41% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 9 Feb 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Revenue55.2Operating income20.6Net income20.1EPS, diluted0.74Fiscal year 2021Revenue60.9 +10.2%Operating income−13.4Net income−17.1 −185.2%EPS, diluted−0.63Fiscal year 2022Revenue23.9 −60.7%Operating income−28.9Net income−18.7EPS, diluted−4.31Fiscal year 2023Revenue2.2 −90.6%Operating income−38.1Net income−42.2EPS, diluted−7.64Fiscal year 2024Revenue1.3 −40.9%Operating income−42.9Net income−34.1EPS, diluted−3.68Fiscal year 2025Revenue0.0 −100.0%Operating income−49.0Net income13.3EPS, diluted−0.79
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 55.2 60.9 23.9 2.2 1.3 0.0
Growth +10.2% −60.7% −90.6% −40.9% −100.0%
Operating income 20.6 −13.4 −28.9 −38.1 −42.9 −49.0
Net income 20.1 −17.1 −18.7 −42.2 −34.1 13.3
Growth −185.2%
EPS, diluted 0.74 −0.63 −4.31 −7.64 −3.68 −0.79

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2020Operating margin37.2%Net margin36.4%Free cash flow margin−4.9%Fiscal year 2021Operating margin−22.0%Net margin−28.2%Free cash flow margin−14.7%Fiscal year 2022Operating margin−121.0%Net margin−78.4%Free cash flow margin−107.2%Fiscal year 2023Operating margin−1,700.6%Net margin−1,884.5%Free cash flow margin−1,130.7%Fiscal year 2024Operating margin−3,244.9%Net margin−2,579.0%Free cash flow margin−2,618.6%Fiscal year 2025
FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin 37.2% −22.0% −121.0% −1,700.6% −3,244.9% n/a
Net margin 36.4% −28.2% −78.4% −1,884.5% −2,579.0% n/a
Free cash flow margin −4.9% −14.7% −107.2% −1,130.7% −2,618.6% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow10.0Capital expenditure−12.7Free cash flow−2.7Fiscal year 2021Operating cash flow2.0Capital expenditure−10.9Free cash flow−9.0Fiscal year 2022Operating cash flow−23.5Capital expenditure−2.2Free cash flow−25.6Fiscal year 2023Operating cash flow−25.1Capital expenditure−0.2Free cash flow−25.3Fiscal year 2024Operating cash flow−34.3Capital expenditure−0.3Free cash flow−34.6Fiscal year 2025Operating cash flow−44.8Capital expenditure−0.9Free cash flow−45.7
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 10.0 2.0 −23.5 −25.1 −34.3 −44.8
Capital expenditure −12.7 −10.9 −2.2 −0.2 −0.3 −0.9
Free cash flow −2.7 −9.0 −25.6 −25.3 −34.6 −45.7
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2020Cash12.6Shareholders’ equity39.0Fiscal year 2021Cash33.2Shareholders’ equity38.5Fiscal year 2022Cash15.0Shareholders’ equity31.1Fiscal year 2023Cash56.6Shareholders’ equity57.3Fiscal year 2024Cash8.9Shareholders’ equity26.0Fiscal year 2025Cash10.5Shareholders’ equity151.5
FY2020FY2021FY2022FY2023FY2024FY2025
Cash 12.6 33.2 15.0 56.6 8.9 10.5
Shareholders’ equity 39.0 38.5 31.1 57.3 26.0 151.5

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
37.2% −22.0% −121.0% −1,700.6% −3,244.9% n/a
36.4% −28.2% −78.3% −1,884.5% n/a n/a
36.4% −28.2% −78.4% −1,884.5% −2,579.0% n/a
−4.9% −14.7% −107.2% −1,130.7% −2,618.6% n/a
Spending
50.5% 93.9% 152.4% 737.6% 2,287.6% n/a
12.3% 28.1% 68.5% 1,062.9% 1,057.3% n/a
23.0% 18.0% 9.1% 8.8% 25.5% n/a
0.0% n/a n/a n/a n/a 0.0%
Returns
51.6% −44.5% −60.3% −73.6% −131.3% 8.8%
35.6% −21.1% −36.8% −50.3% −77.2% 7.7%
Balance and payout
31.0% 52.5% 39.0% 31.7% 41.2% 12.3%